The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Pooled Analysis of Randomized Clinical Trials
Open accessAbstract
Background and Purpose— Women experience worse outcomes after stroke compared with men. Prior work has suggested sex-based differences in coagulation and fibrinolysis markers in subjects with acute stroke. We explored whether sex might modify the effect of recombinant tissue plasminogen activator (rtPA) on outcomes in patients with acute ischemic stroke. Methods— Using a combined database including subjects from the National Institute of Neurological Disorders and Stroke (NINDS), Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke (ATLANTIS) A and B, and the Second European Cooperative Acute Stroke Study (ECASS II) trials, we examined 90-day outcomes in patients randomized to rtPA versus placebo by sex. We used logistic regression to control for potential confounders. Results— Among 988 women treated between 0 and 6 hours from symptom onset, patients receiving rtPA were significantly more likely than those receiving placebo to have a modified Rankin Score ≤1 (40.5% versus 30.3%, P <0.0008). Among 1190 men, the trend toward benefit in the overall group did not reach statistical significance (38.5% versus 36.7%, P =0.52). An unadjusted analysis showed that women were significantly more likely to benefit from rtPA compared with men ( P =0.04). Controlling for age, baseline National Institutes of Health Stroke Scale, diabetes, symptom onset to treatment time, prior stroke, systolic blood pressure, extent of hypoattenuation on baseline computed tomography scan and several significant interaction terms (including onset to treatment time–by-treatment and systolic blood pressure–by treatment) did not substantially change the strength of the interaction between gender and rtPA treatment ( P =0.04). Conclusions— In this pooled analysis of rtPA in acute ischemic stroke, women benefited more than men, and the usual gender difference in outcome favoring men was not observed in the thrombolytic therapy group. For patients presenting at later time intervals, when the risks and benefits of rtPA are more finely balanced, sex may be an important variable to consider for patient selection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Research works printed but not linked: 30
- 10.1161/circ.99.4.463 · doi:10.1161/circ.99.4.463
- 10.1161/str.31.8.1833 · doi:10.1161/str.31.8.1833
- 10.1111/j.1532-5415.2000.tb04747.x · DOI
- 10.1046/j.1538-7836.2003.00040.x · doi:10.1046/j.1538-7836.2003.00040.x
- 10.1046/j.1365-2141.2001.02916.x · DOI
- 10.1161/str.30.12.2547 · doi:10.1161/str.30.12.2547
- 10.1002/ana.10628 · doi:10.1002/ana.10628
- 10.1161/str.31.4.811 · doi:10.1161/str.31.4.811
- 10.1001/jama.282.21.2019 · DOI · Paper page
- 10.1016/S0140-6736(98)08020-9 · DOI · Paper page
- 10.1016/S0140-6736(04)15692-4 · DOI · Paper page
- 10.1161/str.27.11.2136 · doi:10.1161/str.27.11.2136
- Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, Hu WY, Buchan AM. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol. 2001; 22: 1534–1542.
- 10.1016/S0140-6736(00)02237-6 · DOI · Paper page
- 10.1212/WNL.55.11.1649 · DOI · Paper page
- 10.1002/ana.1058 · DOI
- Kent DM, Ruthazer R, Selker HP. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Stroke. 2003; 3: 464–467.
- 10.1177/026921559701100211 · DOI
- 10.1007/s00415-002-0755-8 · DOI · Paper page
- 10.3109/09638289809166054 · DOI
- 10.1161/01.str.0000083534.81284.c5 · DOI · Paper page
- 10.1161/str.28.11.2119 · doi:10.1161/str.28.11.2119
- Ribó M, Montaner J, Molina CA, Arenillas JF, Rubiera M, Monasterio J, Huertas R, Santamarina E, Mauriño J, Alvarez-Sabín J. Baseline plasma PAI-1 level predicts recanalization, hemorrhagic transformation, and outcome in tPA-treated patients. Stroke. 2004; 35: 292.
- 10.1089/neu.2000.17.367 · DOI · Paper page
- 10.1097/00004647-200004000-00001 · DOI · Paper page
- 10.1161/01.str.0000078562.82918.f6 · DOI · Paper page
- 10.1067/mem.2002.128682 · DOI
- 10.1161/str.32.8.1832 · doi:10.1161/str.32.8.1832
- Giampaoli S. Epidemiology of major age-related diseases in women compared to men. Aging. 2000; 12: 93–105.
- Guralnik JM, Balfour JL, Volpato S. The ratio of older women to men: historical perspectives and cross-national comparisons. Aging. 2000; 12: 321–322.
Cited by
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes
Reeves, M. J., Bushnell, C. D., Howard, G., Gargano, J. W., Duncan, P. W., Lynch, G., Khatiwoda, A., & Lisabeth, L. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70193-5 · Cited by 1,362
Blood-brain barrier dysfunction and recovery after ischemic stroke
Jiang, X., Andjelkovic, A. V., Zhu, L., Yang, T., Bennett, M. V. L., Chen, J., Keep, R. F., & Shi, Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.001 · Cited by 936
Molecular targets in cerebral ischemia for developing novel therapeutics
Mehta, S. L., Manhas, N., & Raghubir, R. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.11.003 · Cited by 708
Demaerschalk, B. M., Kleindorfer, D. O., Adeoye, O. M., Demchuk, A. M., Fugate, J. E., Grotta, J. C., Khalessi, A. A., Levy, E. I., Palesch, Y. Y., Prabhakaran, S., et al. (2016) · Stroke · doi:10.1161/str.0000000000000086 · Cited by 670
Metadata
- Authors
- Kent, D. M., Price, L. L., Ringleb, P., Hill, M. D., & Selker, H. P.
- Venue
- Stroke
- Published
- 2005-01
- Volume
- 36
- Issue
- 1
- Pages
- 62-65
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W3023381640
- Cited by
- 239
- References
- 1
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Pooled Analysis of Randomized Clinical Trials. https://app.cochat.ai/papers/10.1161/01.str.0000150515.15576.29
- The paper
- Kent, D. M., Price, L. L., Ringleb, P., Hill, M. D., & Selker, H. P. (2005). Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Pooled Analysis of Randomized Clinical Trials. Stroke. https://doi.org/10.1161/01.str.0000150515.15576.29
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.